Our Cell & Gene Programmes
Explore the Future of Cell & Gene with Oxford Global
Immerse yourself in a world of scientific insight and unparalleled networking opportunities.
Join us for first-class experiences, where every event is meticulously designed to deliver exceptional value.
13 - 14 June 2024 | London, UK
Gene Therapy Development 2024
Join leaders at the forefront of gene therapy development, offering insights on navigating the latest advancements and challenges in gene therapy production.
Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies.
Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more
Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials
Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies
Agenda at a Glance
- Day One, Track 1: Vector Development
- Day One, Track 2: Gene Therapy Manufacturing & Supply Chain
- Day One, Track 3: Pre-clinical and Clinical Therapeutic Development
- Day Two, Track 1: Gene Therapy Analytics
- Day Two, Track 2: Emerging Targets and Gene Editing Tools and Strategies
06 - 08 November 2024 | London, UK
Cell & Gene 2024
Join our premier event to unlock the potential of the CGT value chain, from discovery and development to successful commercialisation
- Delve into critical issues in cell culture, cell line development, and bioprocessing. Engage with presentations and interactive sessions aimed at translating research discoveries into safe and effective therapies for patients
- Embark on a journey through CGT development and commercialisation. Explore the latest advancements and challenges presented by industry leaders across tracks covering clinical trial design, regulatory matters, and IP challenges
- Fast-track your CGT manufacturing pipeline by connecting with and learning from innovators pushing the boundaries of therapy manufacture. Topics span from supply chain logistics to considerations between autologous and allogenic therapies.
Agenda at a Glance
13th Annual Cell Culture Congress
- Day One & Day Two | Track 1: Cell Line Engineering & Development
- Day One | Track 2 & Day 2 | Track 3: Cell Culture & Cell Therapies Quality Control & Analysis
- Day Two | Track 2: Upstream & Downstream Bioprocessing: Novel Technologies & Continuous Processing
- Day Three | Track 1: Preclinical Assessments: Research & Development
- Day Three | Track 2: Optimising Cell Culture Media
11th Annual Advanced Therapy Development Congress
- Day One | Track 3: Gene Therapy Discovery & Development
- Day One | Track 4: CGT Commercialisation
- Day Two | Track 4: CGT Development
- Day Three | Track 3: CGT Clinical Development & Clinical Trial
- Day Three, Track 4: iPSCs and Stem Cell Therapy Development
10th Annual Cell & Gene Therapy Manufacturing Congress
- Day One | Track 5: Supply Chain & Logistics
- Day Two | Track 5: Strategies for CGT Manufacturing, Supply Chain & Commercialisation
- Day Three | Track 5: CGT Manufacturing Technologies: Automation, Digitalisation & Scale-Up
04 - 05 December 2024 | San Diego, CA
Cell & Gene US 2024
Connecting leaders from every stage of the value chain to drive advanced therapy development and novel biologics processing
- Reduce upstream & downstream bioprocessing bottlenecks of novel biologics and advanced therapies, enabling stability, quality and clonality
- From novel therapeutic approaches in every stage of the drug pipeline, through to the considerations of developing scalable, optimized, commercial products, connect with experts from every stage of the value chain
- Overcome critical challenges in the cost & complexity of cell & gene manufacturing, with discussion of the most innovative technologies, tools and ideas that will enable scalable manufacture of these products
Agenda at a Glance
Cell Culture & Bioprocessing Congress US
- Day One, Track 1: Cell Line Engineering Ensuring Stability, Quality & Clonality
- Day One, Track 2: Downstream Bioprocessing: Novel Technologies & Continuous Processing
- Day Two, Track 1: Cell Lines For Therapeutic Development
- Day Two, Track 2: Upstream Bioprocessing: Optimization & Quality Control
Advanced Therapy Development Congress & Cell and Gene Therapy Manufacturing Congress US
- Day One, Track 1: Innovative Target Discovery & Design
- Day One, Track 2: Ensuring Successful Clinical Trials & Operations
- Day One, Track 3: Cell Therapy Manufacturing At Scale
- Day Two, Track 1: Preclinical & Translational Strategies
- Day Two, Track 2: Manufacturing Viral & Non-Vector Based Gene Therapies
- Day Two, Track 3: Supply Chain & Logistics